European Journal of Pharmaceutics and Biopharmaceutics, volume 123, pages 59-70

Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes

Publication typeJournal Article
Publication date2018-02-01
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor4.9
ISSN09396411, 18733441
General Medicine
Pharmaceutical Science
Biotechnology
Abstract
Folate receptors (FR) are cellular markers highly expressed in various cancer cells. Here, we report on the synthesis of a novel folate-containing lipoconjugate (FC) built of 1,2-di-O-ditetradecyl-rac-glycerol and folic acid connected via a PEG spacer, and the evaluation of the FC as a targeting component of liposomal formulations for nucleic acid (NA) delivery into FR expressing tumor cells. FR-targeting liposomes, based on polycationic lipid 1,26-bis(cholest-5-en-3β-yloxycarbonylamino)-7,11,16,20-tetraazahexacosan tetrahydrochloride (2X3), lipid helper dioleoylphosphatidylethanolamine (DOPE) and novel FC, formed small compact particles in solution with diameters of 60 ± 22 nm, and were not toxic to cells. Complexes of NAs with the liposomes were prepared at various nitrogen to phosphate ratios (N/P) to optimize liposome/cell interactions. We showed that FR-mediated delivery of different nucleic acids mediated by 2X3-DOPE/FC liposomes occurs in vitro at low N/P (1/1 and 2/1); under these conditions FC-containing liposomes display 3-4-fold higher transfection efficiency in comparison with conventional formulation. Lipoplexes formed at N/P 1/1 by targeted liposomes and cargo (Cy7-labeled siRNA targeting MDR1 mRNA) in vivo efficiently accumulate in tumor (∼15-18% of total amount), and kidneys (71%), and were retained there for more than 24 h, causing efficient downregulation of p-glycoprotein expression (to 40% of control) in tumors. Thus, FC containing liposomes provide effective targeted delivery of nucleic acids into tumor cells in vitro and in xenograft tumors in vivo.

Citations by journals

1
2
3
4
5
6
7
Pharmaceutics
Pharmaceutics, 7, 22.58%
Pharmaceutics
7 publications, 22.58%
Russian Journal of Bioorganic Chemistry
Russian Journal of Bioorganic Chemistry, 4, 12.9%
Russian Journal of Bioorganic Chemistry
4 publications, 12.9%
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America, 1, 3.23%
Proceedings of the National Academy of Sciences of the United States of America
1 publication, 3.23%
Journal of Drug Delivery Science and Technology
Journal of Drug Delivery Science and Technology, 1, 3.23%
Journal of Drug Delivery Science and Technology
1 publication, 3.23%
Cancers
Cancers, 1, 3.23%
Cancers
1 publication, 3.23%
Current Drug Delivery
Current Drug Delivery, 1, 3.23%
Current Drug Delivery
1 publication, 3.23%
Nucleic Acid Therapeutics
Nucleic Acid Therapeutics, 1, 3.23%
Nucleic Acid Therapeutics
1 publication, 3.23%
Biomedicines
Biomedicines, 1, 3.23%
Biomedicines
1 publication, 3.23%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 3.23%
International Journal of Molecular Sciences
1 publication, 3.23%
Journal of Molecular Medicine
Journal of Molecular Medicine, 1, 3.23%
Journal of Molecular Medicine
1 publication, 3.23%
European Journal of Pharmaceutical Sciences
European Journal of Pharmaceutical Sciences, 1, 3.23%
European Journal of Pharmaceutical Sciences
1 publication, 3.23%
Chinese Chemical Letters
Chinese Chemical Letters, 1, 3.23%
Chinese Chemical Letters
1 publication, 3.23%
Molecular Therapy - Methods and Clinical Development
Molecular Therapy - Methods and Clinical Development, 1, 3.23%
Molecular Therapy - Methods and Clinical Development
1 publication, 3.23%
International Journal of Biological Macromolecules
International Journal of Biological Macromolecules, 1, 3.23%
International Journal of Biological Macromolecules
1 publication, 3.23%
Process Biochemistry
Process Biochemistry, 1, 3.23%
Process Biochemistry
1 publication, 3.23%
Molecular Pharmaceutics
Molecular Pharmaceutics, 1, 3.23%
Molecular Pharmaceutics
1 publication, 3.23%
ChemNanoMat
ChemNanoMat, 1, 3.23%
ChemNanoMat
1 publication, 3.23%
Pharmaceutical Development and Technology
Pharmaceutical Development and Technology, 1, 3.23%
Pharmaceutical Development and Technology
1 publication, 3.23%
Journal of Materials Chemistry B
Journal of Materials Chemistry B, 1, 3.23%
Journal of Materials Chemistry B
1 publication, 3.23%
Fundamental and Clinical Pharmacology
Fundamental and Clinical Pharmacology, 1, 3.23%
Fundamental and Clinical Pharmacology
1 publication, 3.23%
1
2
3
4
5
6
7

Citations by publishers

2
4
6
8
10
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 10, 32.26%
Multidisciplinary Digital Publishing Institute (MDPI)
10 publications, 32.26%
Elsevier
Elsevier, 6, 19.35%
Elsevier
6 publications, 19.35%
Pleiades Publishing
Pleiades Publishing, 4, 12.9%
Pleiades Publishing
4 publications, 12.9%
Wiley
Wiley, 2, 6.45%
Wiley
2 publications, 6.45%
Proceedings of the National Academy of Sciences (PNAS)
Proceedings of the National Academy of Sciences (PNAS), 1, 3.23%
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 3.23%
Bentham Science
Bentham Science, 1, 3.23%
Bentham Science
1 publication, 3.23%
Mary Ann Liebert
Mary Ann Liebert, 1, 3.23%
Mary Ann Liebert
1 publication, 3.23%
Springer Nature
Springer Nature, 1, 3.23%
Springer Nature
1 publication, 3.23%
American Chemical Society (ACS)
American Chemical Society (ACS), 1, 3.23%
American Chemical Society (ACS)
1 publication, 3.23%
Taylor & Francis
Taylor & Francis, 1, 3.23%
Taylor & Francis
1 publication, 3.23%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 3.23%
Royal Society of Chemistry (RSC)
1 publication, 3.23%
2
4
6
8
10
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Shmendel E. V. et al. Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes // European Journal of Pharmaceutics and Biopharmaceutics. 2018. Vol. 123. pp. 59-70.
GOST all authors (up to 50) Copy
Shmendel E. V., Gladkikh D. V., Chernolovskaya E. L., Markov O. V., Morozova N. G., Maslov M. A., Zenkova M. A., Kabilova T. O., Shmendel E., Gladkikh D. V., Maslov M., Зенкова М. А. Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes // European Journal of Pharmaceutics and Biopharmaceutics. 2018. Vol. 123. pp. 59-70.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.ejpb.2017.11.010
UR - https://doi.org/10.1016%2Fj.ejpb.2017.11.010
TI - Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes
T2 - European Journal of Pharmaceutics and Biopharmaceutics
AU - Shmendel, Elena V
AU - Gladkikh, Daniil V.
AU - Chernolovskaya, Elena L.
AU - Markov, Oleg V
AU - Morozova, Nina G.
AU - Maslov, Mikhail A
AU - Zenkova, Marina A
AU - Kabilova, Tatyana O.
AU - Shmendel, Elena
AU - Gladkikh, Daniil V.
AU - Maslov, Michael
AU - Зенкова, М. А.
PY - 2018
DA - 2018/02/01 00:00:00
PB - Elsevier
SP - 59-70
VL - 123
SN - 0939-6411
SN - 1873-3441
ER -
BibTex
Cite this
BibTex Copy
@article{2018_Shmendel,
author = {Elena V Shmendel and Daniil V. Gladkikh and Elena L. Chernolovskaya and Oleg V Markov and Nina G. Morozova and Mikhail A Maslov and Marina A Zenkova and Tatyana O. Kabilova and Elena Shmendel and Daniil V. Gladkikh and Michael Maslov and М. А. Зенкова},
title = {Targeted delivery of nucleic acids into xenograft tumors mediated by novel folate-equipped liposomes},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2018},
volume = {123},
publisher = {Elsevier},
month = {feb},
url = {https://doi.org/10.1016%2Fj.ejpb.2017.11.010},
pages = {59--70},
doi = {10.1016/j.ejpb.2017.11.010}
}
Found error?